Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Lowy

The National Cancer Institute named Douglas Lowy its acting director, following the departure of Harold Varmus. Lowy has been NCI's deputy director since July 2010. A cancer researcher for 40 years, he received the National Medal of Technology and Innovation from President Obama last year for work that resulted in the development of the human papillomavirus vaccine. He is a member of the National Academy of Sciences and the Institute of Medicine of the NAS. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.